Regulatory Dendritic Cells
Showing 1 - 25 of >10,000
Kidney Transplant, Renal Transplant Recipients Trial in Pittsburgh (DCreg: 0.5 million cells/kg+SOC, DCreg: 1.2 million
Recruiting
- Kidney Transplant
- Renal Transplant Recipients
- DCreg: 0.5 million cells/kg+SOC
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh, Starzl Transplantation Institute
Apr 30, 2021
GVHD Trial in Tampa (Cultured Treg cells)
Completed
- Graft Versus Host Disease
- Cultured Treg cells
-
Tampa, FloridaH Lee Moffitt Cancer Center
Nov 2, 2022
Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))
Completed
- Melanoma
- Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 12, 2023
Telitacicept on Transitional Regulatory B Cells in Systemic
Recruiting
- Telitacicept
- +2 more
-
Jinan, Shandong, ChinaYanfeng Hou
Nov 19, 2023
Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and
Not yet recruiting
- Multiple Sclerosis
- Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
- (no location specified)
Oct 10, 2022
Blood Endothelium Progenitor Cells and Dendritic Cells as
Completed
- Atherosclerosis
- Restenosis
-
Edegem, Antwerpen, BelgiumUniversitair Ziekenhuis Antwerpen
Nov 3, 2022
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)
Completed
- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin
- TAPCells vaccine
-
Santiago, RM, ChileFaculty of Medicine, University of Chile
Nov 21, 2023
Living Donor Liver Transplantation Trial in Pittsburgh (Donor-derived DCreg)
Active, not recruiting
- Living Donor Liver Transplantation
- Donor-derived DCreg
-
Pittsburgh, PennsylvaniaUPMC
Sep 7, 2022
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))
Recruiting
- Acute Myeloid Leukemia
- +4 more
- TregGraft (Orca-T)
-
Duarte, California
- +13 more
Oct 28, 2021
Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)
Not yet recruiting
- Postoperative Prevention of Tumor
- Oral NMN combined with DC cell vaccine
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Sep 6, 2023
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
Interleukins in Periodontal Disease Progression
Recruiting
- Periodontitis
- Gingivitis
- Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
-
Assiut, Asyut, EgyptDepartment of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023
Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))
Not yet recruiting
- Lymphoma Leukemia
- allogeneic CAR19 regulatory T cells (CAR19-tTreg)
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Dec 6, 2022
Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)
Not yet recruiting
- Epithelial Ovarian Cancer
- Ovarian Carcinoma
- XP-DC vaccinations
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Mar 6, 2023
Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)
Terminated
- Castration Resistant Prostate Cancer, CRPC
- Cellgram-DC-PC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022
Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed
Recruiting
- Triple Negative Breast Cancer
- HER2-negative Breast Cancer
- HER2 - primed Dendritic cells
- HER3 - primed Dendritic cells
-
Tampa, FloridaMoffitt Cancer Center
Jan 10, 2023
Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived
Not yet recruiting
- Islet Transplantation
- Infusion of recipient T regulatory cell
- Infusion of concomitant Donor Derived Vertebral Bone Marrow
-
Palo Alto, CaliforniaStanford University
Jul 25, 2023
Ovarian Cancer Trial in Seoul (Cellgram-DC)
Terminated
- Ovarian Cancer
- Cellgram-DC
-
Seoul, Korea, Republic ofAsan medical center
Dec 29, 2022
Nasopharyngeal Cancer Trial in Jakarta (Auto-Dendritic Adjuvant Therapy, Allo-Dendritic-Secretome Adjuvant Therapy)
Not yet recruiting
- Nasopharyngeal Cancer
- Auto-Dendritic Adjuvant Therapy
- Allo-Dendritic-Secretome Adjuvant Therapy
-
Jakarta, IndonesiaPT Prodia StemCell Indonesia
Mar 1, 2022
Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)
Recruiting
- Aplastic Anemia
- Expanded autologous T regulatory cells
-
London, United KingdomKing's College Hospital
Aug 16, 2022
Living Donor Liver Transplantation Trial in Pittsburgh (Regulatory Donor-Derived Dendritic Cell infusion)
Active, not recruiting
- Living Donor Liver Transplantation
- Regulatory Donor-Derived Dendritic Cell infusion
-
Pittsburgh, PennsylvaniaUPMC
Sep 2, 2021
Uveal Melanoma Trial in Germany (Autologous Dendritic Cells loaded with autologous Tumor RNA)
Active, not recruiting
- Uveal Melanoma
- Autologous Dendritic Cells loaded with autologous Tumor RNA
-
Erlangen, Bayern, Germany
- +7 more
Nov 29, 2022
Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML
Recruiting
- Non Small Cell Lung Cancer
- Solid Tumor
- Avelumab
- +3 more
-
Jette, Brussels, Belgium
- +1 more
Sep 9, 2022